Global Cervical Artificial Disc Market to Hit $1 Billion by 2012

WALTHAM, Mass., March 18 /PRNewswire/ -- According to Millennium Research Group's (MRG) Global Markets for Spinal Nonfusion Technologies 2008 report, which covers markets in the US, Europe, and Asia Pacific regions, the global cervical artificial disc market will grow from a value of just under $60 million in 2007 to approximately $1 billion in 2012.

Several factors will be integral in facilitating growth in this market, including increased adoption of Synthes Spine's and Medtronic Spinal and Biologics' cervical artificial discs in the US, the release of newly designed products from numerous different competitors, a familiar surgical approach to that of anterior cervical fusion, as well as an increased use of multiple discs in a single procedure.

"Both patients and surgeons alike are excited about cervical artificial disc technology," says Kevin Flewwelling, Manager of MRG's Orthopedics division. "Patients benefit from the increased motion preservation associated with cervical artificial discs, as well as the shorter recovery times, which enables them to return quickly to their regular lifestyles. Surgeons, on the other hand, are comfortable with the surgical technique and are attracted by the technologies' ability to restore physiological motion and minimize adjacent-level disc disease."

The Global Markets for Spinal Nonfusion Technologies 2008 report covers the artificial disc, dynamic stabilization, nuclear disc replacement, annulus repair, and facet arthroplasty markets. Industry competitors include Abbott Spine, Aesculap Implant Systems, Anulex Technologies, Biomet Spine, Cervitech, DePuy Spine, LDR Spine, Medtronic Spinal and Biologics/Kyphon, NuVasive, Paradigm Spine, Raymedica, Scient'x, SpineVision, Stryker Spine, Synthes Spine, Trans1, and Zimmer Spine.

About Cervical Artificial Discs

With age, intervertebral discs may begin to dehydrate and lose their ability to retain water, contributing to severe pain and decreased mobility. Artificial discs were developed to treat chronic back pain while allowing for the preservation of physiological vertebral motion through proper intervertebral spacing and stability.

About Millennium Research Group

Millennium Research Group (http://www.MRG.net), a Decision Resources, Inc. company (http://www.DecisionResources.com), is the global authority on medical technology market intelligence and a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Amy Krohn
    Millennium Research Group
    416-364-7776 x101
    akrohn@mrg.net